Showing 1811-1820 of 7247 results for "".
Dr. Chan Discusses Experience with Gemini Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-chan-discusses-experience-with-gemini-laser/19471/“Gemini is an extremely effective non-ablative skin rejuvenation laser. And by combining the 532 KTP lasers with the long pulse 1064 YAG, we can achieve non-ablative skin rejuvenations in terms of reductions of pigmentations, fine lines, pore size and vessel improvement.” & #8212Professor HenryFinding the Right Medication for the Right Patient with Atopic Dermatitis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37180/Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, explains how to select the optimal therapeutic option for each different atopic dermatitis patient.Pushing the Envelope in PN Research
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37181/Raja Sivamani, MD, MS, AP, an integrative dermatologist and Adjunct Associate Professor of Clinical Dermatology at the University of California, Davis, discusses how research to help understand different aspects of prurigo nodularis can help develop therapeutics that can be life-changing for patientCoding for Superficial Radiation Therapy
https://practicaldermatology.com/series/c-suite-chats/coding-for-superficial-radiation-therapy/56364/Joseph C. Sardano, Chairman and CEO of Sensus Healthcare, discusses the issue of insurance denials for noninvasive skin cancer treatments such as superficial radiation therapy (SRT), and a new solution for ensuring predictable payment.SAFE Step Act Update
https://practicaldermatology.com/series/skin-minute/safe-step-act-update/54846/Colby Evans, MD, former chair of the National Psoriasis Foundation Board of Directors, discusses the progress of the SAFE Step Act, which he said continues to garner bipartisan support and could advance in Congress this year.Strategies for Treating Patients on GLP-1 Receptor Agonists and More
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/strategies-for-treating-patients-on-glp-1-receptor-agonists-and-more/54646/Suneel Chilukuri, MD, discusses key takeaways from the “What’s My Treatment? How to Combine Dermal Filler, Neuromodulators, Laser/Light/RF Devices/Microneedling and Cosmeceuticals Symposium” workshop at Maui Derm Hawaii 2026.Turning Acne Treatment Strategies Upside-Down
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/turning-acne-treatment-strategies-upside-down/54645/Julie Harper, MD, discusses key takeaways from the “Acne and Rosacea: Update 2026” session at Maui Derm Hawaii 2026.Rosacea: New and Old Medications, Isotretinoin, and Flushing
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/rosacea-new-and-old-medications-isotretinoin-and-flushing/54654/Hilary Baldwin, MD, discusses key takeaways from the “Acne and Rosacea: Update 2026” session at Maui Derm Hawaii 2026.Wound Closure After Mohs Surgery
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/wound-closure-after-mohs-surgery/54648/Anna Bar, MD, discusses key takeaways from the “Wound Closures” workshop at Maui Derm Hawaii 2026.Addressing Itch in Prurigo Nodularis Clinical Trials
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37170/Raja Sivamani, MD, MS, AP, an integrative dermatologist and Adjunct Associate Professor of Clinical Dermatology at the University of California, Davis, addresses how future prurigo nodularis trials could better address the heterogeneity in disease burden and patient-reported outcomes.